How to buy PubMatic shares | 11 March price $57.03

How to buy PubMatic shares | $57.03

Own PubMatic shares in just a few minutes. Share price changes are updated daily.

PubMatic, Inc (PUBM) is a leading software-application business based in the US. It opened the day at $55.48 after a previous close of $52.68. During the day the price has varied from a low of $55.01 to a high of $59.35. The latest price was $57.03 (25 minute delay). PubMatic is listed on the NASDAQ and employs 548 staff. All prices are listed in US Dollars.

How to buy shares in PubMatic

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PUBM in this case.
  5. Research PubMatic shares. The platform should provide the latest information available.
  6. Buy your PubMatic shares. It's that simple.
The whole process can take as little as 15 minutes.

PubMatic share price

Use our graph to track the performance of PUBM stocks over time.

PubMatic shares at a glance

Information last updated 2021-03-11.
Open$55.48
High$59.35
Low$55.01
Close$57.03
Previous close$52.68
Change $4.35
Change % 8.2574%
Volume 346,930
Information last updated 2021-04-16.
52-week range$14.5 - $76.958
50-day moving average $53.8283
200-day moving average $43.228
Wall St. target price$60.33
Dividend yield N/A (0%)
Earnings per share (TTM) N/A
Promoted
eToro Free Stocks

Invest in PubMatic shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Fees for buying 10x PubMatic shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Fineco logo £0 No minimum £6.94
£415.10 total
Capital at risk
eToro Free Stocks logo £0 $200 £2.04
£410.20 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.87
£409.03 total
Capital at risk
Stake logo £0 £50 £2.07
£410.23 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.06
£424.22 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £14.14
£422.30 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £14.63
£422.79 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy PubMatic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

PubMatic price performance over time

Historical closes compared with the last close of $57.03

1 month (2021-03-19) 21.94%

Is PubMatic under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

PEG ratio

PubMatic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 10.299. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PubMatic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

PubMatic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.6 million (£0.0 million).

The EBITDA is a measure of a PubMatic's overall financial performance and is widely used to measure a its profitability.

Financials

Revenue TTM $148.7 million
Operating margin TTM 21.35%
Gross profit TTM $107.6 million
Return on assets TTM 6.86%
Return on equity TTM 21.3%
Profit margin 17.89%
Market capitalisation $2.7 billion

TTM: trailing 12 months

How to short and sell PubMatic shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "PUBM.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 3.0 million PubMatic shares held short by investors – that's known as the "short interest". This figure is 23.6% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting PubMatic shares can be evaluated.

Short interest ratio (SIR)

PubMatic's "short interest ratio" (SIR) is the quantity of PubMatic shares currently shorted divided by the average quantity of PubMatic shares traded daily (recently around 781271.61458333). PubMatic's SIR currently stands at 3.84. In other words for every 100,000 PubMatic shares traded daily on the market, roughly 3840 shares are currently held short.

However PubMatic's short interest can also be evaluated against the total number of PubMatic shares, or, against the total number of tradable PubMatic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PubMatic's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 PubMatic shares in existence, roughly 60 shares are currently held short) or 0.4388% of the tradable shares (for every 100,000 tradable PubMatic shares, roughly 439 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PubMatic.

Find out more about how you can short PubMatic stock.

PubMatic share dividends

We're not expecting PubMatic to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

  • How to buy Supernus Pharmaceuticals shares | $26.29

    Ever wondered how to buy shares in Supernus Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Supernus Pharmaceuticals.

  • How to buy Shaw Communications shares | $19.0009

    Ever wondered how to buy shares in Shaw Communications? We explain how and compare a range of providers that can give you access to many brands, including Shaw Communications.

  • How to buy Rhythm Pharmaceuticals shares | $26.34

    Ever wondered how to buy shares in Rhythm Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Rhythm Pharmaceuticals.

  • How to buy Revolution Medicines shares | $47.26

    Ever wondered how to buy shares in Revolution Medicines? We explain how and compare a range of providers that can give you access to many brands, including Revolution Medicines.

  • How to buy Proto Labs shares | $135.4

    Ever wondered how to buy shares in Proto Labs? We explain how and compare a range of providers that can give you access to many brands, including Proto Labs.

  • How to buy Prevail Therapeutics shares

    Ever wondered how to buy shares in Prevail Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Prevail Therapeutics.

  • How to buy Ontrak shares | $32.01

    Ever wondered how to buy shares in Ontrak? We explain how and compare a range of providers that can give you access to many brands, including Ontrak.

  • How to buy NovaBay Pharmaceuticals shares | $0.9762

    Ever wondered how to buy shares in NovaBay Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including NovaBay Pharmaceuticals.

  • How to buy Norbord shares

    Ever wondered how to buy shares in Norbord? We explain how and compare a range of providers that can give you access to many brands, including Norbord.

  • How to buy ManTech International shares | $81.88

    Ever wondered how to buy shares in ManTech International? We explain how and compare a range of providers that can give you access to many brands, including ManTech International.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site